Tesp2 Inhibitors
Tesp2 inhibitors represent a chemical class designed to interact with a specific protein known as Tesp2. The action of these inhibitors is predicated on their ability to modulate the function of this protein through molecular interactions. Proteins like Tesp2 are often involved in complex biochemical pathways within organisms, and the precise modulation of their activity can induce significant changes in the behavior of these pathways. Tesp2 inhibitors, therefore, are the result of targeted chemical synthesis where the molecules are constructed to fit into the active site or a regulatory domain of the Tesp2 protein, akin to a key fitting into a lock. This interaction is typically characterized by the formation of non-covalent bonds such as hydrogen bonds, ionic bonds, Van der Waals forces, and sometimes transient covalent bonds, which alter the conformation of the protein, and thus, its activity.
The chemical structure of Tesp2 inhibitors is diverse, reflecting the variability in the binding sites of the target protein. These inhibitors can be small organic molecules, peptides, or even larger macromolecules that have been optimized for high affinity and specificity to Tesp2. The design process often involves an iterative cycle of structure-activity relationship (SAR) studies, where chemists synthesize a series of compounds with slight variations in their structure to determine the features that optimize interaction with Tesp2. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling play a pivotal role in guiding the medicinal chemists in crafting these molecules. The resulting inhibitors are usually characterized by their kinetic parameters, such as the dissociation constant (K_d), which signifies the affinity of the inhibitor for the Tesp2 protein, and the inhibition constant (K_i), which provides insight into the potency of the inhibitor under biological conditions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a butyrophenone antipsychotic that antagonizes dopamine D2 receptors, which can indirectly decrease dopamine signaling. Reduced dopamine signaling may lower the activity of Tesp2 if Tesp2 is involved in pathways regulated by dopamine. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the synaptic cleft. This can alter serotonergic signaling, potentially affecting Tesp2 if it plays a role in serotonin-modulated pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can suppress the mTOR signaling pathway, which is involved in cell growth and proliferation. If Tesp2 is implicated in these cellular processes, mTOR inhibition could result in reduced Tesp2 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K), which could lead to reduced AKT signaling. If Tesp2 is downstream of PI3K/AKT signaling, inhibition by Wortmannin could reduce Tesp2 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor specifically targeting BCR-ABL, c-KIT, and PDGFR. By inhibiting these kinases, Imatinib could affect Tesp2 function if Tesp2 is regulated by any of these signaling pathways. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin, thus blocking T-cell activation. If Tesp2 is involved in T-cell function or regulation, its activity could be decreased by Cyclosporin A. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which leads to increased acetylation of histones and affects gene expression. If Tesp2 is regulated by acetylation status, Trichostatin A could decrease its activity through epigenetic modulation. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and inhibits their depolymerization, affecting cell division. If Tesp2 is involved in the cell cycle, this stabilization could decrease Tesp2's activity through disruption of normal cell cycle progression. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Pyrithione inhibits the division of fungal cells and may also disrupt copper metabolism in cells. If Tesp2 is sensitive to copper levels, this disruption could lead to decreased Tesp2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, leading to decreased AKT phosphorylation and signaling. If Tesp2 functions downstream of the PI3K/AKT pathway, LY294002 could decrease its activity. | ||||||